FDA 483 - Neil S. Sadick, M.D. - October 09, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Neil S. Sadick, M.D. (Sadick Anesthetic Surgery & Dermatology) in New York, NY, revealed that an investigation was not conducted in accordance with the signed statement of investigator and investigational plan. The firm failed to re-consent subjects after protocol amendments that altered study design or increased potential risk, and did not ensure documented medical histories were available to verify inclusion and exclusion criteria for some participants. These findings indicate significant deviations from established clinical trial protocols and subject protection requirements.
ID · 0ae2e728-52ba-4565-83aa-d8f2ebc8a66d